[go: up one dir, main page]

AR015906A1 - Compuesto derivado de fenilo o piridilo, composicion farmaceutica que lo contiene y su uso en la preparacion de un medicamento - Google Patents

Compuesto derivado de fenilo o piridilo, composicion farmaceutica que lo contiene y su uso en la preparacion de un medicamento

Info

Publication number
AR015906A1
AR015906A1 ARP980102939A ARP980102939A AR015906A1 AR 015906 A1 AR015906 A1 AR 015906A1 AR P980102939 A ARP980102939 A AR P980102939A AR P980102939 A ARP980102939 A AR P980102939A AR 015906 A1 AR015906 A1 AR 015906A1
Authority
AR
Argentina
Prior art keywords
group
ring
nr2c
rnr3c
nr2r2a
Prior art date
Application number
ARP980102939A
Other languages
English (en)
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26758382&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR015906(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Du Pont filed Critical Du Pont
Publication of AR015906A1 publication Critical patent/AR015906A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen inhibidores de factor Xa con un grupo de especificidad P1 neutro de formula (I) o estereoisomeros o sales aceptables para uso farmacéutico delos mismos, donde el anillo D es fenilo o piridilo; E se selecciona entre F, Cl, Br, I, OH, alcoxi C1-3, SH, alquil-S C1-3, S(O)R3b, S(O)2R3a, S(O)2NR2R2a, yOCF3; R se selecciona entre H, F, CL, Br, I, OR3, SR3, CO2R3, NO2 y CH2OR3; como alternativa, E y R se combinan para formar metilendioxi o etilendioxi; M seselecciona del grupo de formulas(a) - (tt) donde: J es O o S; Ja es NH o NR1a; Z se selecciona entre un enlace, alquileno C1-4, (CH2)rO(CH2)r,(CH2)rNR3(CH2)r,(CH2)rC(O)(CH2)r, (CH2)rC(O)O(CH2)r, (CH2)rOC(O)(CH2)r, (CH2)rC(O)NR3(CH2)r, (CH2)rNR3C(O)(CH2)r, (CH2)rOC(O)O(CH2)r, (CH2)rOC(O)NR3(CH2)r,(CH2)rNR3C(O)O(CH2)r, (CH2)rNR3C(O)NR3(CH2)r, (CH2)rS(O)p(CH2)r, (CH2)rSO2NR3(CH2)r, (CH2)rNR3SO2(CH2)r, y (CH2)rNR3SO2NR3(CH2)r, con la condicion de que Z noforma un enlace NN, N-O, N-S, NCH2N, NCH2O, o NCH2S con el anillo M o el grupo A; R1a y R1b están independientemente ausentes o se seleccionan entre-(CH2)r-R1, -CH=CH-R1, NCH2R1, OCH2R1, SCH2R1, NH(CH2)2(CH2)tR1, O(CH2)2(CH2)tR1, y S(CH2)2(CH2)tR1; como alternativa, R1a y R1b cuando están unidosa átomos de C adyacentes, juntocon los átomos con los cuales están unidos forman un anillo saturado de 5-8 miembro, un anillo parcialmente saturado oinsaturado sustituido con 0-2 R4 y que contiene entre 0-2 heteroátomos seleccionados entre el grupo formado por N, O y S; como alternativa, cuando Z esC(O)NH y R1a está unido a un carbono del anillo adyacente a Z, en ese caso R1a es un C(O) que reemplaza el hidrogeno de la amida de Z para formar una imidacíclica; R1 se selecciona entre H, alquilo C1-3, F, Cl, Br, I, -CN, -CHO, (CF2)rCF3-(CH2)rOR2, NR2R2a, C(O)R2c, OC(O)R2, (CF2)rCO2R2c, S(O)pR2b, NR2(CH2)rOR2,CH(=NR2c)NR2R2a, NR2c(O)R2b, NR2c(O)NHR2b, NR2c(O)2R2a, OC(O)NR2aR2b, C(O)NR2R2a, C(O)NR2(CH2)rOR2, SO2NR2R2a, NR2SO2R2b, residuo carbocíclico C3-6 sustituidocon 0-2 R4, y un sistema heterocíclico de 5 a 10 miembros que contiene entre 1-4 heteroátomos seleccionados del grupo formado por N, O, y S sustituido con 0-2
ARP980102939A 1997-06-19 1998-06-19 Compuesto derivado de fenilo o piridilo, composicion farmaceutica que lo contiene y su uso en la preparacion de un medicamento AR015906A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87888597A 1997-06-19 1997-06-19
US7669198P 1998-02-27 1998-02-27

Publications (1)

Publication Number Publication Date
AR015906A1 true AR015906A1 (es) 2001-05-30

Family

ID=26758382

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102939A AR015906A1 (es) 1997-06-19 1998-06-19 Compuesto derivado de fenilo o piridilo, composicion farmaceutica que lo contiene y su uso en la preparacion de un medicamento

Country Status (22)

Country Link
EP (1) EP0991625B1 (es)
JP (1) JP2002507968A (es)
KR (1) KR20010013977A (es)
AR (1) AR015906A1 (es)
AT (1) ATE296805T1 (es)
AU (1) AU8150398A (es)
BR (1) BR9810151A (es)
CA (1) CA2290982A1 (es)
DE (1) DE69830403T2 (es)
EA (1) EA200000048A1 (es)
EE (1) EE9900584A (es)
ES (1) ES2239806T3 (es)
HR (1) HRP980334A2 (es)
HU (1) HUP0003906A2 (es)
IL (1) IL133526A0 (es)
LV (1) LV12516B (es)
NO (1) NO996316L (es)
PL (1) PL337831A1 (es)
PT (1) PT991625E (es)
SI (1) SI20208A (es)
SK (1) SK174699A3 (es)
WO (1) WO1998057937A2 (es)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1012150A4 (en) * 1997-05-19 2002-05-29 Sugen Inc HETEROARYLCARBOXAMIDE COMPOUNDS THAT ARE EFFECTIVE OF DISEASES CAUSED BY PROTEIN-TYROSIN-KINASE
JP2001526268A (ja) * 1997-12-22 2001-12-18 デュポン ファーマシューティカルズ カンパニー Ｘａ因子阻害剤としての、オルト−置換Ｐ１を有する、窒素含有複素環式芳香族化合物
US6271237B1 (en) 1997-12-22 2001-08-07 Dupont Pharmaceuticals Company Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors
WO1999041231A1 (en) 1998-02-17 1999-08-19 Ono Pharmaceutical Co., Ltd. Amidino derivatives and drugs containing the same as the active ingredient
DE69920888T2 (de) 1998-03-27 2006-02-02 Bristol-Myers Squibb Pharma Co. Disubstituierte pyrazoline und triazoline als faktor xa inhibitoren
EP1101759A4 (en) * 1998-07-31 2001-12-12 Nippon Soda Co PHENYLAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICATIONS FOR HYPERLIPEMY
AU3127900A (en) * 1998-12-23 2000-07-31 Du Pont Pharmaceuticals Company Thrombin or factor xa inhibitors
CA2360740A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
DE60003025T2 (de) 1999-04-02 2004-03-18 Bristol-Myers Squibb Pharma Co. Arylsulfonyle als faktor xa inhibitoren
HUP0202708A3 (en) * 1999-04-15 2004-12-28 Bristol Myers Squibb Co Cyclic protein tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
CA2380727A1 (en) 1999-07-16 2001-01-25 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor xa inhibitors
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
EP1226123A1 (en) * 1999-11-03 2002-07-31 Du Pont Pharmaceuticals Company Cyano compounds as factor xa inhibitors
US6407256B1 (en) 1999-11-03 2002-06-18 Bristol Myers Squibb Co Cyano-pyrrole, cyano-imidazole, cyano-pyrazole, and cyano-triazole compounds as factor Xa inhibitors
MY138097A (en) 2000-03-22 2009-04-30 Du Pont Insecticidal anthranilamides
US6506771B2 (en) 2000-06-23 2003-01-14 Bristol-Myers Squibb Pharma Company Heteroaryl-phenyl heterobicyclic factor Xa inhibitors
WO2002000647A1 (en) 2000-06-23 2002-01-03 Bristol-Myers Squibb Pharma Company Heteroaryl-phenyl substituted factor xa inhibitors
US6586418B2 (en) 2000-06-29 2003-07-01 Bristol-Myers Squibb Company Thrombin or factor Xa inhibitors
EP1332131A2 (en) 2000-11-07 2003-08-06 Bristol-Myers Squibb Company Acid derivatives useful as serine protease inhibitors
HUP0303901A2 (hu) 2000-11-07 2004-03-01 Bristol-Myers Squibb Co. Szerin proteáz inhibitorokként alkalmazható savszármazékok és ezeket tartalmazó gyógyszerkészítmények
US6906192B2 (en) 2000-11-07 2005-06-14 Bristol Myers Squibb Company Processes for the preparation of acid derivatives useful as serine protease inhibitors
MY142967A (en) 2001-08-13 2011-01-31 Du Pont Method for controlling particular insect pests by applying anthranilamide compounds
AR036872A1 (es) 2001-08-13 2004-10-13 Du Pont Compuesto de antranilamida, composicion que lo comprende y metodo para controlar una plaga de invertebrados
US7375232B2 (en) 2001-08-15 2008-05-20 E.I. Du Pont De Nemours And Company Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
CN1865258A (zh) 2001-08-15 2006-11-22 纳幕尔杜邦公司 用于控制无脊椎害虫的邻位取代的芳基酰胺化合物
ATE417829T1 (de) 2001-08-16 2009-01-15 Du Pont Substituierte anthranilamide und ihre verwendung als pesticide
TW200724033A (en) 2001-09-21 2007-07-01 Du Pont Anthranilamide arthropodicide treatment
CN101357914A (zh) 2001-09-21 2009-02-04 百时美施贵宝公司 含有内酰胺的化合物及其衍生物作为Xa因子的抑制剂
TWI331526B (en) 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
JP2005512975A (ja) 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ 抗菌薬として有用なイソキサゾリン誘導体
CN100349890C (zh) 2002-01-22 2007-11-21 纳幕尔杜邦公司 用于防治无脊椎害虫的喹唑啉(二)酮
US7312214B2 (en) 2002-05-10 2007-12-25 Bristol-Myers Squibb Company 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors
CN100335477C (zh) 2002-06-13 2007-09-05 纳幕尔杜邦公司 吡唑甲酰胺杀虫剂
DE10229070A1 (de) * 2002-06-28 2004-01-15 Merck Patent Gmbh Phenylderivate 5
AU2003295491B2 (en) 2002-11-15 2009-10-08 E.I. Du Pont De Nemours And Company Novel anthranilamide insecticides
HUE025683T2 (hu) 2002-12-03 2016-04-28 Pharmacyclics Llc VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok
US7247736B2 (en) 2002-12-23 2007-07-24 4Sc Ag Method of identifying inhibitors of DHODH
EP1578741B1 (en) * 2002-12-23 2011-07-13 4Sc Ag Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7365094B2 (en) 2002-12-23 2008-04-29 4Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
WO2004056746A1 (en) 2002-12-23 2004-07-08 4Sc Ag Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
IN243219B (es) 2003-01-28 2010-10-01 Du Pont
US7122557B2 (en) 2003-03-18 2006-10-17 Bristol-Myers Squibb Company Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors
EP1620405A2 (en) * 2003-05-01 2006-02-01 Abbott Laboratories Pyrazole-amides and sulfonamides as sodium channel modulators
US20040220170A1 (en) * 2003-05-01 2004-11-04 Atkinson Robert N. Pyrazole-amides and sulfonamides as sodium channel modulators
WO2005012256A1 (en) 2003-07-22 2005-02-10 Astex Therapeutics Limited 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
TWI376370B (en) * 2003-07-23 2012-11-11 Synta Pharmaceuticals Corp Compounds for inflammation and immune-related uses
ES2629414T3 (es) 2003-12-26 2017-08-09 Kyowa Hakko Kirin Co., Ltd. Derivados de tiazol
AU2005219788B2 (en) 2004-03-05 2010-06-03 Nissan Chemical Corporation Isoxazoline-substituted benzamide compound and noxious organism control agent
EP1735284A1 (en) 2004-03-18 2006-12-27 Pfizer Limited N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
JO2540B1 (en) 2004-07-01 2010-09-05 اي.اي.ديو بونت دي نيمورز اند كومباني Control factors for pests from invertebrate insects include a symbiotic mixture of anthranilamide
AU2005281934A1 (en) * 2004-09-06 2006-03-16 F. Hoffmann-La Roche Ag 4-aminomethyl benzamidine derivatives and their use as factor VIIA inhibitors
KR20140018997A (ko) 2005-01-07 2014-02-13 신타 파마슈티칼스 코프. 염증 및 면역 관련 용도를 위한 화합물
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
JPWO2006137527A1 (ja) 2005-06-23 2009-01-22 協和発酵キリン株式会社 チアゾール誘導体
BRPI0613045A2 (pt) * 2005-07-15 2010-12-14 Hoffmann La Roche aminas cÍclicas fundidas a heteroarila
EP1924575A1 (en) 2005-08-24 2008-05-28 E.I.Du pont de nemours and company Anthranilamides for controlling invertebrate pests
TWI324908B (en) 2006-01-05 2010-05-21 Du Pont Liquid formulations of carboxamide arthropodicides
KR100875596B1 (ko) * 2006-01-31 2008-12-23 동화약품공업주식회사 신규한 벤즈아미딘 유도체, 그의 제조방법 및 이를포함하는 약학 조성물
CA2658523C (en) * 2006-07-31 2012-06-12 Activesite Pharmaceuticals, Inc. Inhibitors of plasma kallikrein
EP1894928A1 (en) 2006-08-29 2008-03-05 PheneX Pharmaceuticals AG Heterocyclic fxr binding compounds
AU2007320906A1 (en) 2006-11-13 2008-05-22 Pfizer Products Inc. Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
US8716312B2 (en) 2008-11-19 2014-05-06 Merck Sharp & Dohme Corporation Inhibitors of diacylglycerol acyltransferase
EP2513063B1 (de) 2009-12-15 2013-11-06 Bayer CropScience AG Verfahren zur herstellung von 1-alkyl-/1-aryl-5-pyrazolcarbonsäurederivaten
EP2512466A4 (en) 2009-12-18 2013-07-03 Activesite Pharmaceuticals Inc PRODRUGS OF INHIBITORS OF PLASMATIC KALLICREIN
EP2630128A4 (en) * 2010-10-20 2013-08-28 Biota Scient Management VIRUS POLYMERASE INHIBITORS
WO2012081916A2 (ko) * 2010-12-17 2012-06-21 한국화학연구원 인다졸 유도체 및 이를 함유하는 살충제 조성물
PL2691379T3 (pl) 2011-03-31 2017-05-31 Bayer Intellectual Property Gmbh Skuteczne chwastobójczo i grzybobójczo 3-fenyloizoksazolino-5-karboksamidy i 3-fenyloizoksazolino-5-tioamidy
EP2697196A1 (en) 2011-04-13 2014-02-19 Activesite Pharmaceuticals, Inc. Prodrugs of inhibitors of plasma kallikrein
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
WO2013050757A1 (en) 2011-10-03 2013-04-11 Respivert Limited 1-pyrazolyl-3- (4- ( (2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1 - yl) ureas as p38 map kinase inhibitors
EP2578582A1 (en) 2011-10-03 2013-04-10 Respivert Limited 1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 MAP kinase inhibitors
EP2900644B1 (de) * 2012-09-25 2016-09-21 Bayer CropScience AG Herbizid und fungizid wirksame 5-oxy-substituierte 3-phenylisoxazolin-5-carboxamide und 5-oxy-substituierte 3-phenylisoxazolin-5-thioamide
BR112015007578B1 (pt) 2012-10-02 2020-05-05 Bayer Cropscience Ag Uso não terapêutico de compostos, compostos, composições emétodo não terapêutico para controlar pragas compreendendoos referidos compostos
EP2961746B1 (en) 2013-02-28 2018-01-03 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
MY199131A (en) 2014-03-07 2023-10-17 Biocryst Pharm Inc Human plasma kallikrein inhibitors
CN104086501B (zh) * 2014-07-23 2016-02-17 张远强 一种par-1拮抗剂、其制备方法和用途
CN104086503B (zh) * 2014-07-23 2015-10-14 张远强 Par-1拮抗剂及其用途
CN104072439B (zh) * 2014-07-23 2015-11-04 张远强 卤素取代的四氮唑苯乙酮化合物、其制备方法和用途
CN104086500B (zh) * 2014-07-23 2015-08-26 张远强 一种par-1拮抗剂及其用途
CN104072437B (zh) * 2014-07-23 2015-10-14 张远强 双取代的四氮唑苯乙酮化合物、其制备方法和用途
CN104086497B (zh) * 2014-07-23 2016-03-02 张远强 三唑希夫碱类化合物、其制备方法和用途
CN104086498B (zh) * 2014-07-23 2015-11-18 张远强 末端取代的三唑希夫碱类结构的化合物、其制备方法和用途
CN104072434B (zh) * 2014-07-23 2015-12-02 张远强 间位取代的四氮唑苯乙酮化合物、其制备方法和用途
CN104072435B (zh) * 2014-07-23 2015-11-04 张远强 双烷基取代的四氮唑苯乙酮化合物和用途
CN104072436B (zh) * 2014-07-23 2015-10-14 张远强 对位取代的四氮唑苯乙酮化合物、其制备方法和用途
CN104072432B (zh) * 2014-07-23 2015-12-30 张远强 含苯基取代三唑希夫碱类结构的化合物、其制备方法和用途
CN104086493B (zh) * 2014-07-23 2016-05-18 张远强 末端取代的苯基三唑希夫碱结构的化合物及其用途
CN104072431B (zh) * 2014-07-23 2015-11-18 张远强 烷氧基取代的苯基三唑希夫碱结构的化合物及用途
CN104086502B (zh) * 2014-07-23 2015-10-14 张远强 卤代四氮唑苯乙酮化合物、其制备方法和用途
CN104072438B (zh) * 2014-07-23 2015-10-14 张远强 二烷氧代四氮唑苯乙酮化合物、其制备方法和用途
CN104086492B (zh) * 2014-07-23 2015-12-30 张远强 抗血栓化合物、其制备方法和用途
RS58889B1 (sr) 2014-08-29 2019-08-30 Torrent Pharmaceuticals Ltd Jedinjenja indanil uree koja inhibiraju p38 map kinazu
CN104529928A (zh) * 2015-01-13 2015-04-22 佛山市赛维斯医药科技有限公司 一类恶二唑亚砜化合物、其制备方法和用途
EA202090018A1 (ru) 2017-06-13 2020-05-26 Байер Акциенгезельшафт Гербицидно-активные 3-фенилизоксазолин-5-карбоксамиды тетрагидро- и дигидрофурановых карбоксамидов
UA126240C2 (uk) 2017-06-13 2022-09-07 Баєр Акціенгезельшафт Гербіцидно активний 3-фенілізоксазолін-5-карбоксамід тетрагідро- та дигідрофуранкарбонових кислот та складних ефірів
ES2984279T3 (es) 2017-08-17 2024-10-29 Bayer Ag 3-fenil-5-trifluorometilisoxazolin-5-carboxamidas de ácidos y ésteres ciclopentilcarboxílicos con efecto herbicida
US12319664B2 (en) 2018-01-25 2025-06-03 Bayer Aktiengesellschaft Herbicidally active 3-phenylisoxazoline-5-carboxamides of cyclopentenylcarboxylic acid derivatives
CA3133025A1 (en) 2019-03-12 2020-09-17 Bayer Aktiengesellschaft Herbicidally active 3-phenylisoxazoline-5-carboxamides of s-containing cyclopentenyl carboxylic acid esters
WO2021138540A1 (en) 2020-01-03 2021-07-08 Berg Llc Polycyclic amides as ube2k modulators for treating cancer
KR20240005848A (ko) * 2021-05-05 2024-01-12 유니버시티 칼리지 카디프 컨설턴츠 리미티드 인지 장애의 치료에 유용한 헤테로아릴 화합물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134987A (en) * 1976-01-14 1979-01-16 Huppatz John L Compounds and compositions
ES488768A0 (es) * 1979-02-22 1981-02-16 Monsanto Co Un procedimiento para preparar acido 2-(3-aril-5-isoxazolil)-benzoico
US4226877A (en) * 1979-05-14 1980-10-07 Abbott Laboratories Pyrazoles active in the central nervous system
EP0028489B1 (en) 1979-11-05 1983-10-05 Beecham Group Plc Enzyme derivatives, and their preparation
DE3420985A1 (de) * 1983-10-15 1985-04-25 Bayer Ag, 5090 Leverkusen Substituierte 5-acylamino-1-phenylpyrazole
IL73419A (en) * 1983-11-07 1988-02-29 Lilly Co Eli 1h-pyrazole-4-(thio)carboxamide derivatives,their preparation and herbicidal compositions containing them
DE3540839A1 (de) * 1985-11-18 1987-05-27 Bayer Ag 1-aryl-pyrazole
DE3633840A1 (de) * 1986-10-04 1988-04-14 Hoechst Ag Phenylpyrazolcarbonsaeurederivate, ihre herstellung und verwendung als pflanzenwachstumsregulatoren und safener
DE3706993A1 (de) * 1987-03-05 1988-09-15 Bayer Ag 5-amino-3-halogenalkyl-1-aryl-pyrazole
JPS6425763A (en) * 1987-04-24 1989-01-27 Mitsubishi Chem Ind Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
DE3808896A1 (de) * 1988-03-17 1989-09-28 Hoechst Ag Pflanzenschuetzende mittel auf basis von pyrazolcarbonsaeurederivaten
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
DE4013723A1 (de) * 1990-04-28 1991-10-31 Basf Ag 5-(1,2,4-triazol-1-ylmethyl)-isoxazoline
GB9017694D0 (en) 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry
EP0513387B1 (en) * 1990-11-30 2000-03-01 Otsuka Pharmaceutical Co., Ltd. Thiazole derivatives as active oxygen inhibitors
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CA2138649A1 (en) * 1992-07-24 1994-02-03 Raymond Baker Imidazole, triazole and tetrazole derivatives
US5262412A (en) * 1993-03-10 1993-11-16 Merck & Co., Inc. Substituted pyrazoles, compositions and use
CA2174838A1 (en) * 1993-11-24 1995-06-01 John Wityak Novel isoxazoline and isoxazole fibrinogen receptor antagonists
US5446056A (en) 1993-11-24 1995-08-29 The Du Pont Merck Pharmaceutical Company Isoxazoline compounds useful as fibrinogen receptor antagonists
EP0730589B1 (en) 1993-11-24 1998-07-08 The Du Pont Merck Pharmaceutical Company Isoxazoline compounds useful as fibrinogen receptor antagonists
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5563158A (en) * 1993-12-28 1996-10-08 The Dupont Merck Pharmaceutical Company Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
DE4405207A1 (de) * 1994-02-18 1995-08-24 Bayer Ag N-Pyrazolylaniline und N-Pyrazolylaminopyridine
PT813525E (pt) * 1995-03-10 2004-02-27 Berlex Lab Derivados de benzamidina e sua utilizacao como anticoagulantes
IL118007A0 (en) 1995-05-24 1996-08-04 Du Pont Merck Pharma Isoxazoline compounds pharmaceutical compositions containing them and their use

Also Published As

Publication number Publication date
LV12516B (en) 2001-03-20
BR9810151A (pt) 2000-08-08
NO996316D0 (no) 1999-12-17
AU8150398A (en) 1999-01-04
IL133526A0 (en) 2001-04-30
EA200000048A1 (ru) 2000-08-28
DE69830403D1 (de) 2005-07-07
SK174699A3 (en) 2000-08-14
SI20208A (sl) 2000-10-31
ES2239806T3 (es) 2005-10-01
LV12516A (en) 2000-07-20
WO1998057937A2 (en) 1998-12-23
WO1998057937A3 (en) 1999-03-18
EE9900584A (et) 2000-08-15
HRP980334A2 (en) 1999-04-30
EP0991625A2 (en) 2000-04-12
DE69830403T2 (de) 2006-02-02
CA2290982A1 (en) 1998-12-23
JP2002507968A (ja) 2002-03-12
KR20010013977A (ko) 2001-02-26
PT991625E (pt) 2005-10-31
HUP0003906A2 (hu) 2001-05-28
ATE296805T1 (de) 2005-06-15
NO996316L (no) 1999-12-17
PL337831A1 (en) 2000-09-11
EP0991625B1 (en) 2005-06-01

Similar Documents

Publication Publication Date Title
AR015906A1 (es) Compuesto derivado de fenilo o piridilo, composicion farmaceutica que lo contiene y su uso en la preparacion de un medicamento
CL2012000999A1 (es) Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina.
AR068846A1 (es) Compuestos derivados de pirrolo (2,3d)-pirimidina inhibidores de la actividad de pkb, composiciones farmaceuticas que los contienen, proceso de preparacion y uso de los mismos como agentes anticancer
AR048213A1 (es) 1-(4-mono-y di-halometilsulfonilfenil)-2-acilamino-fluorpropanoles analogos al florfenicol
AR011164A1 (es) Compuestos heterociclicos, composiciones farmaceuticas que los comprenden, y metodos para inhibir la liberacion del peptido beta-amiloide y/o su sintesismediante el uso de dichos compuestos
AR016134A1 (es) Compuestos derivados de propil-amida o butil-indanilo, composicion farmaceutica que los contiene y su uso para la fabricacion de un medicamento con metalo-proteinasas inhibidoras de la agrecanasa y matriz extracelular eficaz en el tratamiento de la artritis
BRPI0014901B8 (pt) composto derivado de trifenil-alquenos e composição farmacêutica para uso como moduladores de receptores seletivos de estrogênios
ECSP088457A (es) Compuestos de benzamida útiles como inhibidores de la histona deacetilasa
AR035455A1 (es) Derivados triciclicos de alquilhidroxamato , procesos para su elaboracion, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos
AR049578A1 (es) Derivados de hidantoina, procesos de obtencion y composiciones farmaceuticas
CO6321266A2 (es) Inhibidores limk2 compuestos de los cuales estan hechos y metodologia de uso
AR022820A1 (es) Compuestos derivados de piridopiranoacepinas, en forma de isomeros geometricos u opticos puros o de mezcla de tales isomeros, procedimiento para su preparacion, medicamento y composicion farmaceutica.
DK162629C (da) 2-substituerede 1-aralkyl-imidazoler og farmaceutiske midler der indeholder disse, anvendelse heraf til fremstilling af farmaceutiske midler samt fremgangsmaade til fremstilling heraf
AR043959A1 (es) Derivados de indolona-acetamida, procesos para prepararlos, composiciones farmaceuticas que los contienen y su uso como productos farmaceuticos
AR087470A1 (es) Derivados imidazolicos bifenilenicos y composiciones farmaceuticas que los contienen
CO5690593A2 (es) Nuevos derivados de pirimidin 2-amina
ES525824A0 (es) Un procedimiento para la preparacion de nuevos derivados de acidos benceno butanoicos.
DK1078928T3 (da) Pyridinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
AR062405A1 (es) Derivados de isoindol
AR037928A1 (es) Compuesto de 2-oxopirrolidin 3- sulfonamida, composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento
AR016644A1 (es) Compuestos de 2-aminopiridinas con sustituyentes alcoxi ramificados, composicion farmaceutica y uso para la manufactura de medicamentos
NO964698D0 (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
SE8107387L (sv) Nya fenylalkylaminer, framstellning derav och anvendning som lekemedel
AR018632A1 (es) Compuestos derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene, proceso para su preparacion.